Discover
CMMB
Chemomab Therapeutics Ltd.
1.70
1 x 1.79
1 x 1.92
bid
ask
+
0.08
4.94%
1 @ 07:13 AM
1.74 +0.04 (2.35%)
| Ytd | 3.03% | |
| 1y | -63.36% |
1.61
day range
1.75
1.35
52 week range
4.92
| Open | 1.63 | Prev Close | 1.62 | Low | 1.61 | High | 1.75 | Mkt Cap | 12.24M |
| Vol | 62.14K | Avg Vol | 43.54K | EPS | -1.12 | P/E | N/A | Forward P/E | -41.25 |
| Beta | 0.30 | Short Ratio | 1.15 | Inst. Own | 27.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 1.69 | 200-d Avg | 2.06 | 1yr Est | 8.00 |
| Income Statement | |||
| Operating Expenses | 1.97M | ||
| Research and Development Expense | 1.09M | ||
| Selling, General and Administrative Expense | 881.00K | ||
| Operating Income | -1.97M | ||
| Net Income | -1.87M | ||
| Net Income Common Stock | -1.87M | ||
| Net Income Common Stock (USD) | -1.87M | ||
| Consolidated Income | -1.87M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -1.87M | ||
| Earning Before Interest & Taxes (USD) | -1.87M | ||
| Weighted Average Shares | 510.23M | ||
| Weighted Average Shares Diluted | 510.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.56M | ||
| Cash and Equivalents (USD) | 7.56M | ||
| Investments | 2.80M | ||
| Investments Current | 2.80M | ||
| Trade and Non-Trade Receivables | 3.06M | ||
| Current Assets | 13.43M | ||
| Property, Plant & Equipment Net | 176.00K | ||
| Total Assets | 13.81M | ||
| Current Liabilities | 1.48M | ||
| Total Liabilities | 1.48M | ||
| Accumulated Retained Earnings (Deficit) | -111.62M | ||
| Shareholders Equity | 12.33M | ||
| Shareholders Equity (USD) | 12.33M | ||
| Assets Non-Current | 387.00K | ||
| Trade and Non-Trade Payables | 485.00K | ||